Hemodialysis Patients Clinical Trial
Official title:
A Clinical Study to Investigate the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients
Verified date | November 2021 |
Source | Dong-A ST Co., Ltd. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A clinical study to investigate the pharmacokinetics/ pharmacodynamics and safety/tolerability of Evogliptin in hemodialysis patients
Status | Completed |
Enrollment | 17 |
Est. completion date | May 24, 2021 |
Est. primary completion date | May 24, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 80 Years |
Eligibility | Inclusion Criteria: 1. Subjects who aged 20 to 80 at the time of screening 2. Subjects with 50.0kg=Body Weight=90.0kg and 18.0kg/m2=BMI=27.0kg/m2 3. Subjects who meet the following kidney functions - group1(hemodialysis patients): MDRD-eGFR = 15 mL/min/1.73m2 - group2(helthy control): MDRD-eGFR = 90 mL/min/1.73m2 Exclusion Criteria: 1. Subjects who have a uncontrolled or unstable disease such as liver, nervous system, immune system, respiratory system, endocrine system or blood / tumor disease, cardiovascular disease, mental disorders (mood disorder, obsessive compulsive disorder, etc.) or history 2. Subjects who have a gastrointestinal disease (such as Crohn's disease, ulcers, acute or chronic pancreatitis, etc.) or history of gastrointestinal surgery (except simple appendectomy or hernia surgery) that may affect the absorption of the test drug. 3. Subjects with a history of significant hypersensitivity reaction such as anaphylaxis or angioedema to DPP-IV inhibitors 4. Subjects who have AST (SGOT) and ALT (SGPT) greater than 1.5 times the upper limit of normal range, at the time of screening test including additional tests. |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Seoul National University Hospital | Seoul |
Lead Sponsor | Collaborator |
---|---|
Dong-A ST Co., Ltd. |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | AUClast | Area Under the plasma Concentration versus time curve(AUClast) of Evogliptin | 1day(15day) pre-dose (0), 1, 2, 3, 4, 5, 6, 7, 8, 12, 24, 36, 48 hour post-dose | |
Primary | Cmax | Peak Plasma Concentration(Cmax) of Evogliptin | 1day(15day) pre-dose (0), 1, 2, 3, 4, 5, 6, 7, 8, 12, 24, 36, 48 hour post-dose |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06382701 -
Effect of Aromatherapy on Pain, Anxiety and Satisfaction in Cannulation
|
N/A | |
Completed |
NCT04674930 -
Effects of Exercise Program on Physical Functioning of Hemodialysis Patients.
|
N/A | |
Recruiting |
NCT02245633 -
Correlation Between Vitamin D Levels to ADAMTS13 , VWF and Micro RNA Expression in Diabetic Hemodialysis Patients
|
N/A | |
Recruiting |
NCT01970280 -
Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients.
|
Phase 4 | |
Completed |
NCT06165211 -
Nature-Based Sound Application For Hemodialysis Patients
|
N/A | |
Completed |
NCT06106763 -
Mandala Colouring On Anxiety, Depression, Pain And Quality of Life
|
N/A | |
Completed |
NCT05693584 -
The Effect of Using Virtual Reality Glasses on Pain During Fistula Cannulation in Hemodialysis Patients
|
N/A | |
Completed |
NCT01932853 -
Association Between Dose Dialysis by Kt and Mortality
|
N/A | |
Completed |
NCT01273974 -
The Immunogenicity of Intradermal Influenza Vaccination in Hemodialysis Patients
|
Phase 2/Phase 3 | |
Completed |
NCT04139759 -
THE EFFECT OF HAND AND FOOT MASSAGE ON FATIGUE IN HEMODIALYSIS PATIENTS
|
N/A | |
Not yet recruiting |
NCT05574595 -
Effect on Pain and Comfort Associated With Fistula Puncture
|
N/A | |
Completed |
NCT04175652 -
Effects of Laughter Yoga on Hemodialysis Patients' Plasma-Beta Endorphin Levels, Pain Levels and Sleep Quality
|
N/A | |
Not yet recruiting |
NCT06314243 -
The Impact of Pumpkin Seed Oil Supplementation on Hemodialysis Patients
|
Phase 3 | |
Completed |
NCT01596842 -
Effect of Omega-3 Fatty Acid on Vitamin D Activation
|
Phase 4 | |
Enrolling by invitation |
NCT01896882 -
Dietary Sodium Restriction in Hemodialysis Patients
|
N/A | |
Completed |
NCT00638300 -
Removal of Ligand-bound Iron During Intravenous (IV) Iron Administration in Hemodialysis (HD)
|
N/A | |
Terminated |
NCT00259714 -
Dialysate Sodium Individualization in Hemodialysis
|
Phase 1 | |
Completed |
NCT01846754 -
Prevalence of Fatigue in Hemodialysis Patients
|
N/A | |
Completed |
NCT00491868 -
Clinical Study of R744 to Hemodialysis Patients
|
Phase 3 | |
Not yet recruiting |
NCT06449105 -
The Effect of Mindfulness Compassionate Living Practice on Hemodialysis Patients
|
N/A |